Food and Drug Administration.Use of color on pharmaceutical product labels, labeling, and packaging; Public hearing. Fed Reg.2005; 70(22): 5687–5689.
2.
Institute for Safe Medication Practice.A spectrum of problems with using color. ISMP Medication Safety Alert! November 13, 2003. Available at: www.ismp.org/msaarticles/spectrumprint.htm. Accessed on February 8, 2005.
3.
CohenM.R.ISMP medication error report analysis – Unit-dose capsules for inhalation – An example of how color-coding can contribute to medication errors – Is an antithyroid or antimetabolite needed? Preventing confusion between propylthiouracil and Purinethol. Hosp Pharm.2003; 38(10): 904–906.
4.
MantyjarviM., TuppurainenK.Changes of color-vision in ocular hypertension. Int Ophthalmol.1994; 18(6): 345–349.
5.
BayerA., ThielH.J., ZrennerE., PaulusW., RiedS., SchmidtD.Disorder of color perception and increased glare sensitivity in phenytoin and carbamazepine therapy — ocular side-effects of anticonvulsants. Nervenarzt.1995; 66(2): 89–96.
6.
FraunfelderF.T., LatiesA.M.Visual side effects possibly associated with Viagra. J Toxicol Cutaneous Ocul Toxicol.2000; 19(1): 21–25.
7.
ButtnerT., MullerT., KuhnW.Effects of apomorphine on visual functions in Parkinson's disease. J Neural Transm.2000; 107(1): 87–94.
8.
OkabeM., ItoK.How to make figures and presentations that are friendly to color blind people. J*Fly. November 20, 2002. Available at: http://jfly.iam.u-tokyo.ac.jp/html/color_blind/. Accessed on February 8, 2005.
9.
Karagol-AyanB.Color vision confusion. Universal Usability in Practice. April 2001. Available at: www.otal.umd.edu/uupractice/color/. Accessed on February 8, 2005.
